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Introduction
More than half of the roughly 42  million smokers in the 
United States have made a recent quit attempt, though 
only 6.2% stayed quit for at least six months (Centers for 
Disease Control and Prevention 2011; Jamal et  al. 2014). 
Combined behavioral support and pharmacotherapy can 
significantly enhance cessation, with 6-month quit rates 
as high as 25% in some circumstances (Fiore et  al. 2008; 
Stead and Lancaster 2012). U.S. Clinical and American 
Psychiatric Association Practice Guidelines recommend 
these treatment strategies for all tobacco users, including 
those with mental illness and/or substance use (hereafter 
referred to as behavioral health disorders). However, few 
of the studies on which these recommendations are based 
included tobacco use treatment interventions for smokers 
with behavioral health conditions (Fiore et al. 2008; Ameri-
can Psychiatric Association 2016). While evidence is grow-
ing on the efficacy of combined behavioral counseling and 
pharmacotherapy for this population (Banham and Gilbody 
2010; Stapleton et al. 2008; Gilbody et al. 2015; Evins et al. 
2014), many questions remain understudied, including the 
evaluation of tobacco use treatment programs in different 
settings such as community mental health centers and club 
house programs (Ziedonis et  al. 2008; Aubin et  al. 2012; 
Lee et al. 2011; Baker et al. 2016).
The smoking rate for persons without behavioral health 
conditions has significantly decreased over the past decade, 
but smoking among persons with behavioral health condi-
tions has declined at a much slower rate (Cook et al. 2014). 
Persons with behavioral health conditions smoke at roughly 
twice the rate of those without behavioral health conditions 
(Lasser et  al. 2000; Schroeder and Morris 2010). Smok-
ing rates vary by specific diagnosis, with over 60% smok-
ing rates for persons with schizophrenia (de Leon and Diaz 
Abstract Though persons with behavioral health condi-
tions experience large disparities in tobacco use, questions 
about the efficacy of evidence-based tobacco use treatment 
remain understudied in community health settings. This 
evaluation examined outcomes from eight community-
based tobacco cessation programs for participants with and 
without behavioral health conditions (n = 974 participants). 
The majority (64.8%) of participants reported one or more 
current behavioral health conditions, including mental ill-
ness and/or substance abuse. Participants who used cessa-
tion medication during the program and who attended more 
counseling sessions had an increased likelihood of being 
quit at 4-month follow-up. Quit rates were between 9.8% 
(intent-to-treat rate) and 30.6% (responder rate); behavioral 
health status did not negatively affect reported quit rates. 
Findings add to the growing literature evaluating com-
munity-based interventions within the behavioral health 
population.
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2005) and up to roughly 90% for those in addiction treat-
ment settings (Guydish et al. 2011).
Adults with behavioral health conditions also smoke at 
a greater intensity, consuming 44% of all cigarettes smoked 
by adults (Lasser et al. 2000) while comprising only 22% of 
the nation’s population (Ziedonis et al. 2008). Persons with 
behavioral health conditions are more likely to be nicotine 
dependent and have lower quit rates than persons without 
behavioral health conditions (Centers for Disease Control 
and Prevention 2013; Lasser et al. 2000). However, a sys-
tematic review of literature measuring cessation motivation 
(e.g., stages of change, the contemplation ladder) found that 
smokers with behavioral health conditions have motivation 
to quit comparable to the general population; in the major-
ity of included studies, smokers with behavioral health con-
ditions were distributed similarly to the general population 
within the contemplation stage of smoking cessation (i.e., 
considering quitting in the next 6 months) and the prepa-
ration stage (i.e., planning to quit within the next 30 days) 
(Siru et al. 2009). The increasing disparity in tobacco use 
for those with behavioral health conditions suggests that 
tobacco control interventions have been less effective in 
this population (Cook et al. 2014). Even population-based 
strategies, such as mass media campaigns and increased 
tobacco excise taxes, may be less effective for persons with 
behavioral health conditions compared to the general popu-
lation (Ashton et al. 2014; Paul et al. 2013).
Another reason that the behavioral health population 
experiences some of the largest disparities in tobacco use 
and tobacco-related health outcomes (Williams et al. 2013) 
is that tobacco use treatment for persons with behavioral 
health conditions has been largely ignored. Contributing 
factors to this problem include continued tolerance of the 
idea that smoking is normative self-medicating behavior, 
promotion of harm reduction principles (e.g., tobacco is 
less harmful and a lower treatment priority compared to 
illicit drug use), lack of provider training, the historical 
precedent of allowing or encouraging smoking in behav-
ioral health facilities, and the misconception that cessation 
will aggravate mental illness symptoms (Hall 2007; Zie-
donis et al. 2008; Aubin et al. 2012; Schroeder and Morris 
2010; Prochaska 2010; Mackowick et  al. 2012). Tobacco 
use is often not assessed by behavioral health specialists 
and is rarely included in treatment plans in inpatient set-
tings (Schroeder and Morris 2010), though research indi-
cates tobacco cessation and mental health and substance 
use treatment can occur concurrently without adverse 
effects and is even associated with reduced depression, anx-
iety, and stress (Ziedonis et al. 2008; Schroeder and Morris 
2010; Evins et al. 2015; Prochaska et al. 2008; Banham and 
Gilbody 2010; Taylor 2014).
The relative lack of evaluation of tobacco treatment 
programs in community settings that serve behavioral 
health populations limits development of a more robust 
evidence base. Recent studies report that quitline call-
ers with behavioral health conditions are less likely to 
quit than callers without behavioral health conditions 
(Hebert et al. 2011; Kerkvliet et al. 2015; Lukowski et al. 
2015; Vickerman et al. 2015). However, few quitline pro-
grams tailor services specifically for callers with behav-
ioral health conditions (Rogers and Sherman 2010). In 
community mental health settings, tailored tobacco use 
treatment programs are feasible and well received (Lee 
et  al. 2011), but the evaluation of outcomes from such 
community-based programs is limited (Ziedonis et  al. 
2008; Ashton et  al. 2013). Examining outcomes from 
tobacco use cessation interventions in real-world set-
tings for smokers with behavioral health conditions pro-
vides insight not captured by gold standard controlled 
trials, as trials often exclude persons with mental illness 
and/or substance use (Doolan and Froelicher 2006) and 
results do not necessarily translate seamlessly into com-
munity settings (Miller and Shinn 2005). To fill that gap, 
this study examines outcomes from a state-wide commu-
nity-based tobacco cessation program among participants 
based on their behavioral health status. Specifically, we 
assessed how participants with and without behavioral 
health conditions compared in regard to program uti-
lization (i.e., number of counseling sessions attended 
and NRT use) and program outcomes (i.e., 30-day quit 
at 4-month follow-up). As participants with behavio-
ral health conditions received tailored counseling, we 
hypothesized similar outcomes would be seen among all 
participants regardless of behavioral health status.
Methods
Setting
Eight community-based tobacco cessation programs in 
local health and behavioral health clinics were imple-
mented in 2013 as a component of Connecticut’s Tobacco 
Use Prevention and Control Program. These programs 
were set in various community environments: three pro-
grams were located in health departments, two in behav-
ioral health agencies, two in community health centers, 
and one in a hospital. Programs were contracted by the 
Connecticut Department of Public Health to target high-
risk tobacco users, including those with mental illness 
and substance use. To recruit participants, staff primar-
ily focused outreach and promotional efforts on providers 
within and outside their agency and trained providers on 
tobacco use assessment and referral.
Intervention
Participants who enrolled in the program received face-to-
face counseling from a tobacco treatment specialist in indi-
vidual and/or group settings, including an intensive one-
on-one session at the time of enrollment. All counseling 
activities were based on the 2008 Clinical Practice Guide-
line for Treating Tobacco Use and Dependence (Fiore et al. 
2008). Group sessions were informed by the American 
Lung Association’s “Freedom from  Smoking®” program 
(American Lung Association 2016) and when appropri-
ate, tailored to participants with mental illness using the 
“Learning About Healthy Living” curriculum (Williams 
et al. 2012) developed specifically for that population. Pro-
gram completion was defined as completing five individual 
counseling sessions or eight group sessions; participants 
were able to receive additional counseling sessions after 
official program completion as part of re lapse preven-
tion. In addition to counseling, participants were eligible 
to receive twelve weeks of nicotine replacement therapy 
(NRT) or other cessation medication (i.e., bupropion or 
varenicline), as medically appropriate, free of charge.
Sample
Current smokers (defined as smoking cigarettes within 
the past 30 days) aged 18 and older who enrolled between 
2013 and 2015 and attended at least one counseling session 
were considered for analysis (n = 1086). Participants with 
complete baseline data were included in the final sample 
(n = 974).
Measures
Baseline participant characteristics were self-reported at 
the time of enrollment, including current smoking status, 
health history, and previous quit attempts. Program partici-
pants were considered to have a current behavioral health 
condition if they reported currently receiving counseling, 
treatment, or medication for mental health, emotional, 
behavioral, or substance use problems (including depres-
sion, anxiety, schizophrenia, bipolar disorder, gambling, or 
alcohol or other drug abuse) at the time of enrollment. Out-
comes at 4-month follow-up, such as changes in smoking 
behavior and use of pharmacotherapy while enrolled in the 
program, were also self-reported. Cessation was defined as 
30-day point prevalence abstinence at 4-month follow-up. 
Due to low overall follow-up response rates (31.9%), both 
intent-to-treat quit rate analysis (i.e., a conservative analy-
sis that assumes all non-responders continue to smoke), and 
responder quit rate analysis (i.e., an overestimate of the quit 
rate that excludes all non-responders from the denomina-
tor), were used to estimate program cessation rates.
Data Analysis
Chi square tests for categorical variables and Wil-
coxon–Mann–Whitney tests for nonparametric continuous 
variables were used to identify differences in participant 
characteristics and program utilization among those with 
and without behavioral health conditions. A generalized 
linear model accounting for clustering of participants at 
different program sites was used to examine predictors of 
smoking cessation at 4-month follow-up, adjusting for par-
ticipant and program utilization characteristics identified a 
priori based on prior literature and available baseline data 
(Caponnetto and Polosa 2008), including demographics, 
smoking intensity, previous quit attempts, cessation medi-
cation use, and behavioral health status. The intent-to-treat 
quit rate was the dependent variable in the model (i.e., non-
responders were assumed to be continuing smokers). Data 
were analyzed in SAS Version 9.4 (SAS Institute, Inc., 
Cary, NC).
This study was conducted in accordance with the Dec-
laration of Helsinki, and the protocol was approved by the 
Institutional Review Board at the University of North Caro-
lina at Chapel Hill (Study #14–0651). The authors have no 
conflicts of interest. All authors certify their responsibility 
for this study and manuscript.
Results
Sample
Participants (n = 974) were primarily white (78%), had 
lower educational attainment (63% with high school/GED 
degree or lower), and had government-sponsored insurance 
(73%) (Table 1). Roughly half of participants were heavy 
smokers (47% smoked at least 20 cigarettes per day at the 
time of enrollment), most (85%) had made a previous quit 
attempt, and 65% reported a current behavioral health con-
dition, such as mental illness or substance use, with 18% 
reporting dual diagnosis (i.e., mental health and substance 
use disorder). Participants with a behavioral health condi-
tion were more likely to be younger, non-Hispanic, and 
have Medicaid insurance.
Program Utilization and Outcomes
Participants attended an average of nearly five counseling 
sessions; participants with a behavioral health condi-
tion were slightly more likely than participants without a 
behavioral health condition to complete the program—
defined as completing five individual or eight group coun-
seling sessions—though this difference was not significant 
(44.4% compared to 40.2%, respectively). Nearly half of 
all participants (45%) used NRT or other cessation medi-
cation (i.e., bupropion or varenicline) during the program 
(Table  2); participants with behavioral health condi-
tions were more likely than participants without behavio-
ral health conditions to have used NRT or other cessation 
medication (47.5% compared to 40.2%, respectively; 
p = .03).
Response rates at 4-month follow-up were 31.9%. Fol-
low-up respondents were significantly more likely to be 
female; ages 35 years or older; have Medicare or private 
Table 1  Participant characteristics
a Program participants were considered to have a current behavioral health condition if they reported currently receiving counseling, treatment, or 
medication for mental health, emotional, behavioral, or substance use problems (including depression, anxiety, schizophrenia, bipolar disorder, 
gambling, or alcohol or other drug abuse) at the time of enrollment
b p value from Chi square test (categorical variables) and Wilcoxon–Mann–Whitney test (nonparametric continuous variables)
Total (n = 974) [% (n)] No behavioral health condi-
tion (n = 343) [% (n)]
Behavioral health  conditiona 
(n = 631) [% (n)]
p  valueb
Age
 Mean (SD) 46.0 (13.5) 49.2 (13.2) 44.3 (13.3) <.0001
Gender
 Male 50.6% (493) 48.1% (165) 52.0% (328) .25
 Female 49.4% (481) 51.9% (178) 48.0% (303)
Race
 White 77.6% (756) 74.9% (257) 79.1% (499) .23
 Black 10.7% (104) 12.8% (44) 9.5% (60)
 Other 11.7% (114) 12.2% (42) 11.4% (72)
Ethnicity
 Non-Hispanic 79.3% (772) 74.3% (255) 81.9% (517) .005
 Hispanic 20.7% (202) 25.7% (88) 18.1% (114)
Education
 <High school 23.9% (233) 26.5% (91) 22.5% (142) .13
 High school degree/GED 39.4% (384) 35.3% (121) 41.7% (263)
 Some college+ 36.7% (357) 38.2% (131) 35.8% (226)
Insurance
 Private 20.1% (196) 37.3% (128) 10.8% (68) <.0001
 Medicaid 58.6% (571) 37.6% (129) 70.1% (442)
 Medicare 14.0% (136) 12.8% (44) 14.6% (92)
 Uninsured 7.3% (71) 12.2% (42) 4.6% (29)
Cigarettes per day
 0–10 37.0% (360) 39.1% (134) 35.8% (226) .31
 11–19 15.7% (153) 16.9% (58) 15.1% (95)
 20+ 47.3% (461) 44.0% (151) 49.1% (310)
Previous quit attempt
 Yes 85.1% (829) 86.9% (298) 84.2% (531) .25
 No 14.9% (145) 13.1% (45) 15.9% (100)
Behavioral health condition
 Total 64.8% (631) N/A 100% (631) N/A
 Anxiety 40.6% (395) 62.6% (395)
 Depression 39.0% (380) 60.2% (380)
 Substance use 29.7% (289) 54.2% (289)
 Bipolar disorder 11.8% (115) 18.2% (115)
 Schizophrenia 4.6% (45) 7.1% (45)
 Gambling 1.0% (10) 1.6% (10)
 2 + behavioral health conditions 39.0% (380) 60.2% (380)
 Mental health and substance use 
disorder dual diagnosis
18.2% (177) 28.1% (177)
insurance; have tried to quit tobacco previously; have 
used cessation medication during the program; and have 
completed the program. Response rates did not signifi-
cantly differ by behavioral health status, though follow-up 
respondents were less likely to have a substance use and 
mental health disorder dual diagnosis. As intent-to-treat 
analysis was used in the generalized linear model, partici-
pants who did not respond to follow-up were assumed to 
still be using tobacco. Thus, results should be interpreted 
with caution, as certain groups had significantly lower 
response rates. Intent-to-treat quit rates were 9.8% and 
responder quit rates were 30.6%.
Accounting for clustering of participants at multiple 
program sites, a generalized linear model was used to 
examine the adjusted effects of participant demograph-
ics, smoking characteristics, behavioral health status, 
and program utilization on 30-day quit status at 4-month 
follow-up, using intent-to-treat analysis (Table  3). No 
demographic factors were associated with being quit. The 
likelihood of being quit increased for participants who 
had previously made a quit attempt (AOR = 2.09, 95% 
CI 1.13, 3.87; p = .02), who used NRT or other cessa-
tion medication during the program (AOR = 3.03, 95% CI 
1.42, 6.45; p = .004), and who attended more counseling 
sessions (AOR = 1.15, 95% CI 1.08, 1.21; p < .0001). 
Heavier smokers (i.e., smoking at least 20 cigarettes per 
day at time of enrollment) had lower likelihood of being 
quit (AOR = 0.62, 95% CI 0.38, 0.99; p = .05). No sig-
nificant differences were observed in the likelihood of 
being quit between those with and without a reported 
behavioral health condition or between those with and 
without a mental health and substance use disorder dual 
diagnosis.
Discussion
This study provides evaluation of smoking cessation treat-
ment in real world, community-based settings for smokers 
across a state, with and without behavioral health condi-
tions. Our findings suggest that evidence-based tobacco use 
treatment for smokers with behavioral health conditions 
can be successfully implemented in a variety of commu-
nity-based health and behavioral health settings. Partici-
pants with behavioral health conditions in these programs 
were successfully recruited and treated; roughly 65% of 
the participants enrolled in the programs reported a current 
behavioral health condition, and these participants achieved 
comparable program completion rates and cessation rates 
to participants without behavioral health conditions. These 
results add to the limited literature examining predictors 
of smoking cessation in community-based treatment pro-
grams. Importantly, findings show that the likelihood of 
cessation increased with attending more counseling ses-
sions and using NRT or other cessation medication during 
the program, with no differences in quit rates between par-
ticipants with and without behavioral health conditions or 
between participants with and without a mental health and 
substance use disorder dual diagnosis.
Table 2  Program utilization and smoking status at 4-month follow-up, by behavioral health status
NRT nicotine replacement therapy
a p value from Chi square test (categorical variables) and Wilcoxon–Mann–Whitney test (nonparametric continuous variables)
b Program completion is defined as completing five individual counseling sessions or eight group counseling sessions
Total (n = 974) % (n) No behavioral health condition 
(n = 343) % (n)
Behavioral health condition 
(n = 631) % (n)
p  valuea
Sessions attended
 Mean (SD) 4.7 (3.5) 4.3 (3.1) 4.8 (3.7) .13
Program  completionb
 Yes 42.6% (415) 39.4% (135) 44.4% (280) .13
Used NRT or other cessation medication
 Any cessation medication 45.0% (438) 40.2% (138) 47.5% (300) .03
 NRT 41.9% (408) 38.5% (132) 43.7% (276) .11
 Varenicline 5.1% (50) 3.8% (13) 5.9% (37) .16
 Bupropion 2.0% (19) 1.8% (6) 2.1% (13) .74
30-day quit rate
Response rate 31.9% (311) 35.0% (120) 30.3% (191) .13
Responder quit rate 30.6% (95) 29.2% (35) 31.4% (60) .68
Intent-to-treat quit rate 9.8% (95) 10.2% (35) 9.5% (60) .73
These findings support tobacco use treatment guidelines 
recommending combined counseling and pharmacotherapy 
for tobacco users with behavioral health conditions (Fiore 
et  al. 2008). Results are also consistent with prior studies 
and contribute to growing evidence that treatment can be 
implemented successfully in settings such as community 
mental health centers. For instance, another community-
based smoking cessation program found that smokers with 
mental illness who received behavioral counseling and 
NRT achieved quit rates comparable to smokers without 
mental illness, with no negative impact on mental health 
symptoms (Currie et  al. 2008). Further, relapse preven-
tion conducted in community mental health centers using 
combined cognitive behavioral therapy and varenicline 
improved prolonged abstinence rates compared with cogni-
tive behavioral therapy alone (Evins et al. 2014). Increasing 
efforts are being made to develop and evaluate cessation 
programs specifically for people with mental illness, such 
as the Smoking Cessation Intervention for Severe Mental 
Ill Health Trial, providing tailored behavioral support and 
pharmacotherapy delivered by mental health nurses (Gil-
body et al. 2015).
Systems-level changes within health and behavioral 
health settings, such as integrating tobacco use assess-
ment into providers’ intake processes (McCullough et  al. 
2009), training providers on tobacco use treatment, and 
implementing smoke and tobacco-free policies on facility 
grounds, can help de-normalize smoking among persons 
with behavioral health conditions and staff members and 
encourage the use of evidence-based support. Perceived 
lack of patient interest in quitting and a high demand on 
clinician time and attention are cited as primary barriers to 
delivering tobacco use treatment in community behavioral 
health centers (Brown et al. 2015). However, a single moti-
vational session can encourage tobacco users with behav-
ioral health conditions to utilize cessation counseling and/
or pharmacotherapy (Ferron et  al. 2016), which in turn 
can lead to a higher likelihood of quitting. Increasing dis-
cussion between providers and patients with behavioral 
health conditions about evidence-based cessation treatment 
and improving accessibility to such treatment should be a 
priority.
Limitations
As this evaluation study was naturalistic and utilized data 
from community-based programs that were not designed or 
implemented as part of a formal research study, several lim-
itations exist. To account for potential selection bias result-
ing from a low response rate at follow-up (31.9%), we used 
intent-to-treat analysis, assuming non-responders were con-
tinuing smokers. Future programs should consider offering 
a small incentive to participants or conduct shorter term 
follow up (e.g., 1 and 3 months post program enrollment) to 
facilitate higher follow-up response rates. The possibility of 
reverse causation must be considered in regard to program 
utilization (i.e., counseling sessions and pharmacotherapy) 
as a significant predictor of quit, such that participants who 
made positive changes to their smoking behavior early in 
Table 3  Predictors of smoking abstinence (n = 974)
Self-reported 30-day point prevalence abstinence at 4-month follow-
up using intent-to-treat analysis
AOR adjusted odds ratio, CI confidence interval
a Adjusted odds ratio from a generalized linear model accounting for 
clustering of program participants at eight different program sites and 
adjusted for all listed variables
AOR (95% CI)a p value
Age 1.02 (1.0, 1.05) .06
Gender
 Male Ref –
 Female 0.88 (0.54, 1.43) .60
Race
 White Ref –
 Black 1.08 (0.56, 2.07) .83
 Other 1.25 (0.39, 4.03) .71
Ethnicity
 Non-Hispanic 0 –
 Hispanic 0.97 (0.25, 3.69) .96
Education
 Some college+ Ref –
 High school degree/GED 0.60 (0.31, 1.18) .14
 <High school 1.06 (0.53, 2.13) .87
Insurance
 Private Ref –
 Medicaid 1.31 (0.67, 2.56) .43
 Medicare 1.73 (0.72, 4.16) .22
 Uninsured 0.73 (0.44, 1.22) .24
Cigarettes per day
 0–10 Ref –
 11–19 0.77 (0.30, 1.98) .59
 20+ 0.62 (0.38, 0.99) .05
Previous quit attempt
 No Ref –
 Yes 2.09 (1.13, 3.87) .02
Used NRT or other cessation medication
 No Ref –
 Yes 3.03 (1.42, 6.45) .004
Sessions attended 1.15 (1.08, 1.21) <.0001
Behavioral health condition
 No Ref –
 Yes 0.81 (0.47, 1.38) .43
Mental health and substance use disorder dual diagnosis
 No Ref -
 Yes 0.73 (0.39, 1.37) .32
the program (e.g., tapering, abstaining) were more likely 
to stay engaged and use available NRT or other cessation 
medication and complete more sessions than participants 
experiencing an early set-back that may have led to drop-
out. Finally, conclusions are limited by self-reported data. 
Smoking abstinence was not biologically verified, though 
self-reported smoking status can be valid and is often the 
only method many community-based programs can afford 
to collect data on program outcomes (Wong et  al. 2012). 
Behavioral health conditions were defined broadly with 
no indication of condition severity, rather than by specific 
DSM diagnoses, limiting our ability to offer recommen-
dations based upon specific clinical diagnoses in terms of 
most successful treatment protocol and barriers to quitting. 
For instance, participants with more severe diagnoses may 
have been more likely to discontinue the program or may 
have been less likely to quit, as has been observed in other 
studies (Cook et  al. 2014). Despite these limitations, quit 
rates in this evaluation appear similar to published quit 
rates from other comparable community-based cessation 
programs for smokers with behavioral health conditions 
(Ashton et al. 2013; Currie et al. 2008).
Conclusions
This study addresses a significant challenge of enhancing 
the impact of smoking cessation interventions for those 
with behavioral health conditions, a largely underserved 
group. Findings add to the limited literature evaluating 
community-based interventions, particularly within the 
behavioral health population. Importantly, community pro-
grams in local health and behavioral health agencies were 
able to reach a high proportion of smokers with behavioral 
health conditions and these participants achieved compara-
ble quit success to participants without behavioral health 
conditions. Health professionals should encourage tobacco 
users with behavioral health conditions to participate in 
community cessation programs and behavioral health agen-
cies should consider integrating tobacco use treatment pro-
grams into their services.
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